Fractionated radiation therapy for vestibular schwannoma

Brian J. Jian, Gurvinder Kaur, Eli T. Sayegh, Orin Bloch, Andrew T. Parsa, Igor J. Barani

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Vestibular schwannomas are the most common tumors of the cerebellopontine angle. Multiple management paradigms exist for patients with these benign tumors, including observation, microsurgery, stereotactic radiosurgery, and fractionated radiation therapy, or some combination of these. While the proper course of management is controversial, the goals of therapy are to achieve excellent local tumor control and optimize functional outcomes with as little treatment-related morbidity as possible. Decision-making is tailored to patient-specific factors such as tumor size, clinical presentation, patient age, and goals of hearing preservation. We review the literature in order to summarize the application of fractionated radiation therapy to this tumor entity, where it is used as a primary treatment or, more commonly, as an adjunct therapy. We also provide an overview of the use of fractionated radiation therapy for the preservation of hearing and facial function, and dosing and other technical considerations, in light of the indolent natural history of vestibular schwannomas. We also discuss potential risks associated with this treatment modality, including its effects on temporal bone structures and cranial nerves among other possible complications. Lastly, we outline future directions in this rapidly evolving segment of vestibular schwannoma therapy, which has benefited from the advent of intensity-modulated radiation therapy coupled with stereotactic localization.

Original languageEnglish (US)
Pages (from-to)1083-1088
Number of pages6
JournalJournal of Clinical Neuroscience
Volume21
Issue number7
DOIs
StatePublished - Jul 2014
Externally publishedYes

Fingerprint

Acoustic Neuroma
Radiotherapy
Hearing
Neoplasms
Therapeutics
Microsurgery
Radiosurgery
Cranial Nerves
Temporal Bone
Decision Making
Observation
Morbidity

Keywords

  • Facial preservation
  • Fractionated radiotherapy
  • Hearing preservation
  • Risks
  • Vestibular schwannoma

ASJC Scopus subject areas

  • Surgery
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Jian, B. J., Kaur, G., Sayegh, E. T., Bloch, O., Parsa, A. T., & Barani, I. J. (2014). Fractionated radiation therapy for vestibular schwannoma. Journal of Clinical Neuroscience, 21(7), 1083-1088. https://doi.org/10.1016/j.jocn.2013.11.005

Fractionated radiation therapy for vestibular schwannoma. / Jian, Brian J.; Kaur, Gurvinder; Sayegh, Eli T.; Bloch, Orin; Parsa, Andrew T.; Barani, Igor J.

In: Journal of Clinical Neuroscience, Vol. 21, No. 7, 07.2014, p. 1083-1088.

Research output: Contribution to journalReview article

Jian, BJ, Kaur, G, Sayegh, ET, Bloch, O, Parsa, AT & Barani, IJ 2014, 'Fractionated radiation therapy for vestibular schwannoma', Journal of Clinical Neuroscience, vol. 21, no. 7, pp. 1083-1088. https://doi.org/10.1016/j.jocn.2013.11.005
Jian, Brian J. ; Kaur, Gurvinder ; Sayegh, Eli T. ; Bloch, Orin ; Parsa, Andrew T. ; Barani, Igor J. / Fractionated radiation therapy for vestibular schwannoma. In: Journal of Clinical Neuroscience. 2014 ; Vol. 21, No. 7. pp. 1083-1088.
@article{9bb28386f91f4d8b9b1172aad0840374,
title = "Fractionated radiation therapy for vestibular schwannoma",
abstract = "Vestibular schwannomas are the most common tumors of the cerebellopontine angle. Multiple management paradigms exist for patients with these benign tumors, including observation, microsurgery, stereotactic radiosurgery, and fractionated radiation therapy, or some combination of these. While the proper course of management is controversial, the goals of therapy are to achieve excellent local tumor control and optimize functional outcomes with as little treatment-related morbidity as possible. Decision-making is tailored to patient-specific factors such as tumor size, clinical presentation, patient age, and goals of hearing preservation. We review the literature in order to summarize the application of fractionated radiation therapy to this tumor entity, where it is used as a primary treatment or, more commonly, as an adjunct therapy. We also provide an overview of the use of fractionated radiation therapy for the preservation of hearing and facial function, and dosing and other technical considerations, in light of the indolent natural history of vestibular schwannomas. We also discuss potential risks associated with this treatment modality, including its effects on temporal bone structures and cranial nerves among other possible complications. Lastly, we outline future directions in this rapidly evolving segment of vestibular schwannoma therapy, which has benefited from the advent of intensity-modulated radiation therapy coupled with stereotactic localization.",
keywords = "Facial preservation, Fractionated radiotherapy, Hearing preservation, Risks, Vestibular schwannoma",
author = "Jian, {Brian J.} and Gurvinder Kaur and Sayegh, {Eli T.} and Orin Bloch and Parsa, {Andrew T.} and Barani, {Igor J.}",
year = "2014",
month = "7",
doi = "10.1016/j.jocn.2013.11.005",
language = "English (US)",
volume = "21",
pages = "1083--1088",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "7",

}

TY - JOUR

T1 - Fractionated radiation therapy for vestibular schwannoma

AU - Jian, Brian J.

AU - Kaur, Gurvinder

AU - Sayegh, Eli T.

AU - Bloch, Orin

AU - Parsa, Andrew T.

AU - Barani, Igor J.

PY - 2014/7

Y1 - 2014/7

N2 - Vestibular schwannomas are the most common tumors of the cerebellopontine angle. Multiple management paradigms exist for patients with these benign tumors, including observation, microsurgery, stereotactic radiosurgery, and fractionated radiation therapy, or some combination of these. While the proper course of management is controversial, the goals of therapy are to achieve excellent local tumor control and optimize functional outcomes with as little treatment-related morbidity as possible. Decision-making is tailored to patient-specific factors such as tumor size, clinical presentation, patient age, and goals of hearing preservation. We review the literature in order to summarize the application of fractionated radiation therapy to this tumor entity, where it is used as a primary treatment or, more commonly, as an adjunct therapy. We also provide an overview of the use of fractionated radiation therapy for the preservation of hearing and facial function, and dosing and other technical considerations, in light of the indolent natural history of vestibular schwannomas. We also discuss potential risks associated with this treatment modality, including its effects on temporal bone structures and cranial nerves among other possible complications. Lastly, we outline future directions in this rapidly evolving segment of vestibular schwannoma therapy, which has benefited from the advent of intensity-modulated radiation therapy coupled with stereotactic localization.

AB - Vestibular schwannomas are the most common tumors of the cerebellopontine angle. Multiple management paradigms exist for patients with these benign tumors, including observation, microsurgery, stereotactic radiosurgery, and fractionated radiation therapy, or some combination of these. While the proper course of management is controversial, the goals of therapy are to achieve excellent local tumor control and optimize functional outcomes with as little treatment-related morbidity as possible. Decision-making is tailored to patient-specific factors such as tumor size, clinical presentation, patient age, and goals of hearing preservation. We review the literature in order to summarize the application of fractionated radiation therapy to this tumor entity, where it is used as a primary treatment or, more commonly, as an adjunct therapy. We also provide an overview of the use of fractionated radiation therapy for the preservation of hearing and facial function, and dosing and other technical considerations, in light of the indolent natural history of vestibular schwannomas. We also discuss potential risks associated with this treatment modality, including its effects on temporal bone structures and cranial nerves among other possible complications. Lastly, we outline future directions in this rapidly evolving segment of vestibular schwannoma therapy, which has benefited from the advent of intensity-modulated radiation therapy coupled with stereotactic localization.

KW - Facial preservation

KW - Fractionated radiotherapy

KW - Hearing preservation

KW - Risks

KW - Vestibular schwannoma

UR - http://www.scopus.com/inward/record.url?scp=84901231545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901231545&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2013.11.005

DO - 10.1016/j.jocn.2013.11.005

M3 - Review article

C2 - 24513160

AN - SCOPUS:84901231545

VL - 21

SP - 1083

EP - 1088

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 7

ER -